Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 8, Issue : 1, Year : 2022
Article Page : 89-97
https://doi.org/10.18231/j.ijceo.2022.017
Abstract
Aims: We studied the clinical profile of patients with raised intraocular pressure (IOP) in closed globe injury and outcome of medical and surgical management.
Methodology : A prospective, interventional study of 32 patients diagnosed with raised IOP following closed globe injury, who presented to a tertiary care centre during the period of November 2018 to May 2020.
Result: Most patients (59%) were young, age group of < 40> 0.7. 68.75% were managed medically and 31.2% surgically. In the medical group, mean initial IOP was 26.18±5.124 mm Hg and at 12 months was 14.83 ± 2.287 mm Hg (p <0>
Conclusion: There was no significant difference between medical and surgical intervention while treating glaucoma secondary to closed globe injury.
Keywords: Trauma, Closed globe injury, Glaucoma, Medical, Surgical intervention
How to cite : Manoj Kumar N, Khayoom N S, Anuradha A, Vidyadevi M, Sharada M, A clinical profile of raised intraocular pressure in closed globe injury and its management. Indian J Clin Exp Ophthalmol 2022;8(1):89-97
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.